Hopp til innhold

Beta talassemi intermedia og minor

Støttende omsorg

Jern kelat-terapi

Iron out for nontransfused thalassemia. (åpner nytt vindu)

Marks PW.

Kilde‎: Blood 2012;120(5):928-9.

Arkiv‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (åpner nytt vindu)

Iron overload in β-thalassemia intermedia: an emerging concern. (åpner nytt vindu)

Musallam KM, Cappellini MD, Taher AT.

Kilde‎: Curr Opin Hematol 2013;20(3):187-92.

Arkiv‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (åpner nytt vindu)

Kosttilskudd og andre støtteterapier

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (åpner nytt vindu)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Kilde‎: Blood 2012;120(7):1531-2.

Arkiv‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (åpner nytt vindu)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (åpner nytt vindu)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Kilde‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Arkiv‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (åpner nytt vindu)

Therapeutic roles of curcumin: lessons learned from clinical trials. (åpner nytt vindu)

Gupta SC, Patchva S, Aggarwal BB.

Kilde‎: AAPS J 2013;15(1):195-218.

Arkiv‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (åpner nytt vindu)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (åpner nytt vindu)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Kilde‎: J Med Assoc Thai 2012;95(1):29-36.

Arkiv‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (åpner nytt vindu)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (åpner nytt vindu)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Kilde‎: Am J Hematol 2013;88(6):503-6.

Arkiv‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (åpner nytt vindu)